Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GGEI Baggs Soon, See DD Below...
$GGEI DD Posted 🟤Soon https://t.co/0VTOek77Zp
— ZINO (@gus94202612) May 9, 2024
MMs, Retails and Shorts are fighting for shares now. Insider sucked the float.
$IGPK : JFHE
— TheStockGuru (@Austria_9999) May 8, 2024
Tweet out
Otc update will be soon pic.twitter.com/KeUeCLoClk
$AVRW markets the Seratopical Wellness skin care line including the advanced new DNA Complex that work from the inside out to deliver powerful and long lasting anti-aging results. https://seralabshealth.com/
IGPK float has to be gone. Launching pad is about done. If it's not already.
$IGPK ACCUMULATION SPIKE pic.twitter.com/ygMVB36Rpb
— Billy Axle Rod (@STOCKACTIVATION) May 8, 2024
$DBGI from earnings call
$DBGI Q1 hints on earnings call
— KIR (@KeepRealistic) April 20, 2024
Q1, 2024 is due May 15th is the game changer 10Q for this company.
Read carefully ⬇️ the excerpt from the CEO on the earnings call and you will see why. pic.twitter.com/L5tNOEsf7B
$IGEX .0008 ^7% NEWS Form 4 Indo Global Exchange(s)
All Content and Data provided by Third-Parties — Terms of Use
Form 4 Indo Global Exchange(s) For: Apr 19 Filed by: European Institute for Entrepreneurship S.L.
10K WIZARD 1:12 PM ET 5/9/2024
http://archive.fast-edgar.com/20240509/A52OB22CZC2R62SZ2K282WY2JBEAZZ22Z262
Filed on: May 9, 2024
$ACGX Interview out: #PeopleVine great interview w/ our founder Jordan Gilman https://lnns.co/duCxsyg0NXP https://peoplevine.com #LuxuryHospitality #UKExpansion #PrivateMembership #GuestExperience #MembershipClubs #MemberPayments #GlobalProfile #CRM $ACGX
$AGBA Article April 28, 2024
'Baby, We Did It': Conor McGregor Joins BKFC Ownership Team in Shocking Announcement
https://www.si.com/fannation/mma/conor-mcgregor-joins-bkfc-ownership-shocking-move
$RTON News - Right On Brands, Inc. Receives First Products from Honey Brands- Retail sales throughout Texas of these innovative and popular products will begin immediately.
https://finance.yahoo.com/news/brands-inc-receives-first-products-120000898.html
$DBGI strongest historical 10Q in 4 days
“In concluding, we are excited to announce our first quarter earnings in May, which we believe show the strength of the business between wholesale shipments and bookings. We'll also have the preliminary results from our outlet store opening in Allen, Texas this weekend. As we have stated, 2024 is the year we expect to experience the inflection point in our business.”
bottom.....................SERV.........................https://stockcharts.com/h-sc/ui?s=SERV&p=W&yr=1&mn=3&dy=0&id=p96837884856
EAST.........................MULN..................................https://stockcharts.com/h-sc/ui?s=EAST&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
$AGBA Article May 07, 2024
Triller and Nasdaq Listed AGBA Group: A Strategic Merger Revealing a $4 Billion Digital Powerhouse
https://okmagazine.com/p/triller-and-nasdaq-listed-agba-group-strategic-merger-revealing-digital-powerhouse/
$EBET 💪Now the Strongest holders enter as the fear is gone , they cannot dismiss this after a long wait it is now written ➡️proceed to the prize is the golden words.🏆🏆🏆
https://investorshub.advfn.com/EBET-Inc-EBET-39391#about
$BURU NUBURU (NYSE American: BURU) Announced a Second Contract With
@NASA
for Next-Generation Blue Laser Space Technology | NASDAQ https://nasdaq.com/press-release/nuburu-announces-a-second-contract-with-nasa-for-next-generation-blue-laser-space
@nuburulasers
$NVDA $AAPL $MSFT $META
MULN.................. .............slap that ask........................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856
FREY.....TUP.....TAOP......LXRX.....MULN.................https://www.stockscores.com/charts/charts/?ticker=FREY
https://www.stockscores.com/charts/charts/?ticker=TAOP
https://www.stockscores.com/charts/charts/?ticker=TUP
https://www.stockscores.com/charts/charts/?ticker=LXRX
https://www.stockscores.com/charts/charts/?ticker=MULN
$AGBA @Triller #4bglobal #Merger "As we progress through the integration and regulatory approval process, our teams remain motivated and confident in the merger’s potential to unlock new growth opportunities and deliver enhanced value to our stakeholders." https://www.tipranks.com/news/the-fly/agba-group-says-triller-merger-ushers-in-new-era-of-value-creation
SOPA looking decent here setting up or another move
maybe.... retail ask now, clear that out...
$BLEG
What is $BLEG up to?
— Dave Oswald (@Dave_Oswald_CEO) May 9, 2024
*Q1 rev from sales grew ~60%
*Q1 rev from white label activities increased by over $100k
*Negotiations underway to white label all products for a company doing over $6m/yr in sales
*validating process for kava extraction contract
*increased assets by >2x
TPET....................CEI.......................BNED.......................https://www.stockscores.com/charts/charts/?ticker=TPET
https://www.stockscores.com/charts/charts/?ticker=BNED
https://www.stockscores.com/charts/charts/?ticker=CEI
BLEG nice tweet out!! Bottom chart
What is $BLEG up to?
— Dave Oswald (@Dave_Oswald_CEO) May 9, 2024
*Q1 rev from sales grew ~60%
*Q1 rev from white label activities increased by over $100k
*Negotiations underway to white label all products for a company doing over $6m/yr in sales
*validating process for kava extraction contract
*increased assets by >2x
$MWRK - MetaWorks Platforms, Inc. is a Web3 company. The Company owns and operates blockchain platforms in the entertainment technology space. It owns and operates movie distribution platforms Vuele.io and MusicFX.io, its fan engagement platform that creates connections between fans and artists using Web3 technologies. The Company's business model is to provide a turnkey set of services to develop and integrate Web 3.0/Metaverse technologies, NFT, blockchain, and cryptocurrency technologies. Its services include strategic planning, project planning, structure development and administration, business plan modeling, technology development support, whitepaper preparation, due diligence reporting, governance planning and management, and movie distribution. The Company also operates artificial intelligence (AI)-powered avatar metaverse platform UtopiaVR.com. The Utopia Metaverse provides a Web-based audio and video conferencing platform that utilizes three-dimensional (3D) Web technology
$BURU Product line. NUBURU Showcases Compact Blue Laser 3rd Generation Light Engine. NUBURU blue lasers also provide higher reliability and better operating efficiency than any other laser type . https://nuburu.net/products/
AGBA moving again 4 magnet
ASTROTECH CORP (ASTC) : 9.90+0.24 (+2.64%)
52w: 7 – 15.11
Shares Outstanding 1.7M
Float 1.21M
Total Cash (mrq) 37.28M
Total Cash Per Share (mrq) 22.86
Total Debt (mrq) 461k
Book Value Per Share (mrq) 25.82
https://www.nasdaq.com/market-activity/stocks/astc/insider-activity
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced that its Board of Directors (the “Board”) has unanimously rejected the unsolicited acquisition proposal from BML Investment Partners, L.P. (“BML”), to acquire all of the outstanding shares of common stock of the Company for $17.25 per share in cash (the “Proposal”). After a thorough review, in consultation with management and its legal advisors, the Board unanimously determined to reject the Proposal because it is not in the best interest of the Company’s stockholders for the reasons set forth below.
“We are confident that the completion of our key strategic projects has the potential to deliver greater value to our stockholders than the current non-binding proposal. Our board has reviewed the BML proposal and believes that it is grossly undervalued,” stated Thomas B. Pickens III, CEO and CTO of Astrotech.
The Proposal is Opportunistic and Significantly Undervalues the Company
• Astrotech’s consolidated balance sheet remains strong with $37 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.
• Year-to-date fiscal year 2024 gross margin increased to 46% from 38% during the comparative period in the prior year, as we continue to benefit from the further refining and ruggedizing of our equipment.
Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect’s TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290. IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA’s thorough evaluation determined that 1st Detect’s pricing is fair and reasonable, that 1st Detect had the requisite capabilities, organizational structure, customer satisfaction and performance history, and that the offered products and services are compliant with applicable laws and regulations.
1st Detect’s TRACER 1000 is a high-performance laboratory instrument of ruggedized mass spectrometry as applied to Explosives Trace Detection (ETD) and Narcotics Trace Detection (NTD). The TRACER 1000 maintains the accuracy of much larger mass spectrometers even though it is only the size of a desktop printer. While mass spectrometry has historically been too costly, bulky, and cumbersome to be used outside of the laboratory, the simple-to-use interface and auto-calibration process of the TRACER 1000 make it easy to use for rank-and-file checkpoint or other security personnel, at a fraction of the cost of traditional mass spectrometers.
The Astrotech Mass Spectrometer Technology™ drives the breakthrough TRACER 1000, as the first certified ETD to employ mass spectrometry. We believe the TRACER 1000 is inexpensive, small, and easy to use, with high resolution and near-zero false alarms. The TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference certification for both checkpoint and cargo security.
1st Detect has engaged with SRI Group LLC, a distinguished GSA provider led by retired Deputy Administrator of the Transportation Security Administration (TSA) John Halinski. He brings extensive knowledge and expertise in international aviation security, intelligence and counterterrorism. He is a member of the Board of Editors for the Government Technology Services Coalition’s magazine and media platform, Homeland Security Today, and is passionate about improving security and implementing the best practices and training procedures to achieve this. SRI Group LLC is a service disabled veteran owned small business, SDVOSB.
About Astrotech
Astrotech is an innovative science and technology company that invents, acquires, and commercializes technological innovations while building scalable companies to maximize shareholder value. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. Astrotech is headquartered in Austin, Texas. For more information, please visit www.astrotechcorp.com.
owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Pro-Control is developing the mass spectrometry technology for use in chemical manufacturing processes. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
About the AgLAB-1000™, the BreathTest-1000™ and the Pro-Control-1000™
This press release contains information about our new products under development, AgLAB-1000, BreathTest-1000 and Pro-Control-1000. Product development involves a high degree of risk and uncertainty, and there can be no assurance that our new products will be successfully developed, achieve their intended benefits, receive full market authorization, or be commercially successful. In addition, FDA approval will be required to market BreathTest-1000 in the United States. Obtaining FDA approval is a complex and lengthy process, and there can be no assurance that FDA approval for BreathTest-1000 will be granted on a timely basis or at all.
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
RAN 10,000% TWO TIMES in last 3 years.
Ready for next 10,000%?
$DBMM> Next 10,000% from .006 is 60 CENTS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174377952
Press Release - April 24, 2024
Digital Clarity Engages Representation in Irvine, California
https://www.accesswire.com/856049/digital-clarity-engages-representation-in-irvine-california
Shareholders Update - February 02, 2024
Company is pleased to announce the acquisition of a major software client headquartered in Austin Texas.
https://www.dbmmgroup.com/shareholder-update-february-02-2024/
Press Release - April 11, 2024
Digital Clarity Announces Strategic Alliance with Leading Transformation Consultancy 1ovmany.
https://www.accesswire.com/852296/digital-clarity-announces-strategic-alliance-with-leading-transformation-consultancy-1ovmany
Direct link to 2024 $DBMM Investor Deck PDF>
https://www.dbmmgroup.com/wp-content/uploads/2024/03/DBMM_Creds_Deck_2024_2.pdf
$DBMM> AWARD WINNING DIGITAL IT COMPANY.
Digital Clarity
https://www.digital-clarity.com/
DBMM Group
https://www.dbmmgroup.com/news-information/
DBMM OTC PINK Current
https://www.otcmarkets.com/stock/DBMM/overview
✅Why chose DBMM?
— DBMM Group Inc. (@dbmm_group) August 3, 2023
Positioned to disrupt multitrillion-dollar global market
Ground-floor investment opportunity
Comparisons to GameStop and AMC
▶️ https://t.co/3gFUr4fIVi#DBMM #OTC pic.twitter.com/fqIdWQMtjy
DBMM is positioned in the multitrillion-dollar global marketing consultancy market
— DBMM Group Inc. (@dbmm_group) October 24, 2023
DBMM’s Digital Clarity has a:
•Extensive black book
•Robust client base
•Current territories: Europe and U.S
•Future territories: U.A.E. and Asia pic.twitter.com/5gqpFWzbUV
NWPN getting closer. Fewest available at .0001 in a very long time. 140 million traded at .0001 with only 19 million left.
CPHI .31->1Mill Float pending dry eye therapeutic device product launch 1st half 2024 !
From CEO On Nov 29th (2023)
—> Ms. Li Zhilin, CEO of China Pharma said: " After passing third-party testing, this product has obtained qualifications to apply for market approval from NMPA. We are actively working to try to launch this product in the first half of next year. We are confident that with the patented technological advantages and our sales channels, the launch of this product will bring excellent treatment experience to every DED patient, which will create value for our shareholders."
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
Source: PR Newswire (US)
HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its Dry Eye Disease (DED) therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration (NMPA) of China.
According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 344 million patients are suffering from DED worldwide, accounting for 30% of the total number of ophthalmic outpatient visits, with an annual increase of 10%. There are about 80 million DED patients in China, ranking second in ophthalmic diseases.
This device has a utility model patent;
Epidemiological research shows that the incidence rate of DED for all the people in China is about 25% to 30%, and about 75% for people over 65-year-old;
In the field of DED and visual fatigue, this product is expected to fill in the market gap of medical therapeutic apparatus; and
The Company has established sales channels in more than 30 provincial and municipal hospitals, as well as OTC markets in China for more than 20 years. This sales network may strongly support the launch and promotion of this device.
Ms. Li Zhilin, CEO of China Pharma said: " After passing third-party testing, this product has obtained qualifications to apply for market approval from NMPA. We are actively working to try to launch this product in the first half of next year. We are confident that with the patented technological advantages and our sales channels, the launch of this product will bring excellent treatment experience to every DED patient, which will create value for our shareholders."
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.
Safe Harbor Statement
Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties may include, but are not limited to: the achievability of financial guidance; success of new product development; unanticipated changes in product demand; increased competition; downturns in the Chinese economy; uncompetitive levels of research and development; and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations, except as required by applicable law or regulation.
Cision View original content:https://www.prnewswire.com/news-releases/china-pharma-holdings-inc-announced-the-completion-of--third-party-testing-of-dry-eye-disease-therapeutic-device-302000153.html
SOURCE China Pharma Holdings, Inc.
Copyright 2023 PR Newswire
TAOP: See me live, below!!! A full-blown ATHEIST, but I'm nonetheless PRAYING hard for the price on this one!!! Heck, whatever works!!
"Please, oh Great Lord --- if you exist, that is --- I only tossed a 'Lotto Ticket' at this one!! And, if you make it SOAR, I'll donate half my profits to Saint Jude's Kids' Hospital! O.K.?? Heck, I ain't askin' for a shinny new LAMBO, for Christ's sake!!"
PSNL......NDLS.....CDLD.......,MULN......https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=CCLD&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=NDLS&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=PSNL&p=D&yr=0&mn=3&dy=0&id=p11960084343
New Director of $IDGR Robert Egeland has done over 28,000 Mortgages.
He is the head of Oxygen Commercial, the newest subsidiary of $IDGR.
https://www.otcmarkets.com/stock/IDGR/news/Ideal-Group-of-Companies-Inc-Appoints-Robert-Egeland-as-Vice-Chairman-and-Begins-Trading-Under-New-Symbol-IDGR?id=429571
Z
A huge wave of new small business loans will be serviced by $IDGR Oxygen Commercial:
According to a survey by the Exit Planning Institute, over 70% of business owners aged 50 or older planned to exit their businesses within the next ten years.
https://www.otcmarkets.com/stock/IDGR/news/Ideal-Group-Subsidiary-Oxygen-Commercial-to-Offer-One-Stop-Loan-Opportunities-Servicing-the-Massive-Boomer-Fueled-Surge-?id=432401
Z
$SPEV Tesla Pulls Back in Charging and Shorepower Steps Up! https://www.localsyr.com/business/press-releases/ein-presswire/710159939/shorepower-technologies-wins-two-state-of-washington-grants-with-project-values-totalling-over-380000/
joined ya, onk onk lets see what this pig can do
it's up by .0006. what am i missing here?
Followers
|
9997
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4973287
|
Created
|
01/10/04
|
Type
|
Free
|
Moderator i_like_bb_stock | |||
Assistants koolmc MOMO vantillian Rainer StockRocket |
![]() | Goal: TO PROVIDE A FORUM FOR BOTH EXPERIENCED AND NOVICE TRADERS TO SHARE THEIR OPINIONS ON STOCKS TRADED ON THE BULLETIN BOARD OR PINK SHEET MARKETS, AS WELL AS THE BIG BOARDS. FUNDAMENTALS, NEWS, RUMORS ARE WELCOME, BUT FOR THE MOST PART, THIS BOARD WILL BE TO SHARE TECHNICAL ANALYSIS. TIMING IS EVERYTHING WHEN BUYING OR SELLING A STOCK, AND TECHNICAL ANALYSIS CAN OFTEN DETERMINE THE APPROPRIATE ACTION TO TAKE. ALL TECHNICAL INDICATORS ARE WELCOME. FOR NOVICE TRADERS, QUESTIONS ARE WELCOMED, AND SOMEONE WILL TRY AND HELP YOU WITH THE ANSWER. I WAS ONCE A NOVICE TRADER, AND KNOW THAT GUIDANCE WOULD HAVE HELPED ME SEVERAL YEARS AGO, SO I WOULD LIKE TO HELP YOU AS MUCH AS POSSIBLE. -- i_like_bb_stock | ![]() |
Rules:1) Spam of any kind will not be tolerated2) There will be times when posters are not in agreement, that is healthy, but please no personal attacks. 3) No specific price preference for the board but these are mostly OTC stocks. 4) Volume is the blood in a stock's veins, so I typically prefer stocks with historical volume, otherwise there is little liquidity for selling the stock if need be. 5) Posting charts and annotations if you have a service that provides it are highly welcome since this provides support for your buy/sell/hold signal. 6) As always, do your due diligence, and remember that there is high risk in these types of stocks. Never trade with money that you cannot afford to loose. 7) If the post is Off Topic, please post with OT prefacing the post. | ![]() |
![]() | Some relevent info:1) For SEC filings I use www.otcmarkets.com.2) For daily charts I use www.stockcharts.com. There is a free service which is time delayed, and then different levels of paid service. 3) To post a chart from stockcharts.com, right click on the chart, click "Copy Image URL". Within the post, right click and click Paste. Remove "http://" then place the chart URL between these tags [*chart]URL[*/chart] (remove the asterisks) 4) For level II, there are various services, IHUB has its own services, individual brokers as well, I use TDAmeritrade, which offers free level II if you have an account. 5) I use equityfeed.com which is critical for any otc trader. It has level II as well, real time news, scanning, and a plethora of things that are needed as a trader. There are various price points based on your needs. 6) For a great listing of stock terms or investor information, use www.investopedia.com or www.investorwords.com. 7) For more info on chart formations, see http://www.chartpatterns.com and http://thepatternsite.com. 8) To find splits, symbol changes etc., use http://otce.finra.org/DailyList 9) Remember also to sell into strength and buy into weakness. When possible, try not to sell at the bid. When a stock is strong, you can usually at least get filled somewhere between the bid/ask, selling at the bid will often hurt the stock, since the market makers make take the bid down further afterwards. 10) For info on stockcharts.com, see the Stockcharts board on the Hub: http://www.investorshub.com/boards/board.asp?board_id=1277 |
Posts Today
|
0
|
Posts (Total)
|
4973287
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |